Cognition enhancing profile of CR 2249, a new NMDA-glycine site modulator

CNS Drug Reviews

Volumn 3, Issue 3, 1997, Pages 245-259

  Lanza, Marco ^a   Makovec, Francesco ^a  

^a Rotta Research Laboratorium   (Italy)

Author keywords

Cognition enhancer; CR 2249; Glycine; Memory; NMDA receptor; Nootropics; Norepinephrine

Indexed keywords

DIZOCILPINE; DRUG METABOLITE; GLYCINE; GLYCINE RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEBOGLAMINE; NORADRENALIN; STRYCHNINE; UNCLASSIFIED DRUG; VALERIC ACID DERIVATIVE;

AREA UNDER THE CURVE; COGNITION; DOSE RESPONSE; DRUG ABSORPTION; DRUG HALF LIFE; DRUG RECEPTOR BINDING; DRUG SYNTHESIS; INTRAVENOUS DRUG ADMINISTRATION; LD 50; MICRODIALYSIS; NONHUMAN; ORAL DRUG ADMINISTRATION; REVIEW; STEREOCHEMISTRY;

EID: 0031420659     PISSN: 1080563X     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1527-3458.1997.tb00326.x     Document Type: Review

References (75)

1. + currents mediates retention of a learned association. Behav Neural Biol 1995;44:278-300.
2. 3H]5,7-dichlorokynurenic acid, a novel radioligand labels NMDA receptor-associated glycine binding sites. Eur J Pharmacol 1991;206:149-154.
3. Bartus RT, Dean RL, Pontecorvo MJ, Flicker C. The cholinergic hypothesis: A historical overview, current perspective, and future directions. Ann NY Acad Sci 1985;444:332-345.
4. Bartus RT, Dean RL, Sherman KA, Friedman E, Beer B. Profound effects of combining choline and piracetam on memory enhancement and cholinergic function in aged rats. Neurobiol Aging 1981;2:105-111.
5. Bashir ZI, Tam B, Collingridge GL. Activation of the glycine site in the NMDA receptor is necessary for the induction of LTP. Neurosci Lett 1990;108:261-266.
6. Bertolino M, Baraldi M, Parenti C, Braghiroli D, DiBella M, Vicini S, Costa E. Modulation of AMPA/kainate receptors by analogues of diazoxide and cyclothiazide in thin slices of rat hippocampus. Receptors Channels 1993;1:267-278.
7. Bhattacharya SK, Upadhyay SN, Jaiswal AK. Effect of piracetam on electroshock induced amnesia and decrease in brain acetylcholine in rats. Indian J Exp Biol 1993;31:822-824.
8. Bliss TVP, Collingridge GL. A synaptic model of memory: Long-term potentiation in the hippocampus. Nature 1993;361:31-39.
9. Chessel IP, Procter AV, Francis PT, Bowen DM. D-cycloserine, a putative cognitive enhancer, facilitates activation of the N-methyl-D-aspartate receptor-ionophore complex in Alzheimer brain. Brain Res 1991;565:345-348.
10. Chan Palay V. Alternation in the locus coeruleus in dementias of Alzheimer's and Parkinson's disease. Prog Brain Res 1991;88:625-630.
11. Cumin R, Bandle EF, Gamzu E, Haefely WE. Effects of a novel compound aniracetam (Ro 13-5057) upon impaired learning and memory in rodents. Psychopharmacology 1982;78:104-111.
12. Davies P. Is it possible to design rational treatments for the symptoms of Alzheimer's disease? Drug Dev Res 1985;5:69-76.
13. Davis KL, Powchik P. Tacrine. Lancet 1995;345:625-630
14. Davis S, Butcher SP, Morris RGM. The NMDA receptor antagonist D-2-amino-5-phosphonopentanoate (D-AP5) impairs spatial learning and LTP in vivo at intracerebral concentrations comparable to those that block LTP in vitro. J Neurosci 1992;12:21-34.
15. 3H]norepinephrine release in rat hippocampal slices. Neuropharmacology 1995;34:141-147.
16. Dingledine R, Hynes MA, King GL. Involvement of N-methyl-D-aspartate receptors in epileptiform bursting in the rat hippocampal slice. J Physiol 1986;380:175-189.
17. D'Souza DC, Bennett A, Karper L, et al. Glycine/D-cycloserine to facilitate NMDA function in humans. Biol Psychiat 1994;35:429.
18. Eisenhofer G, Goldstein DS, Ropchak TG, Nguyen HQ, Keiser HR, Kopin IJ. Source and physiological significance of plasma 3,4-dihydroxyphenylglycol and 3-methoxy-4-hydroxyphenylglycol. J Aut Nervous Syst 1988;24:1-14.
19. Flood JF, Morley JE, Lanthorn TH. Effect on memory processing by D-Cycloserine, an agonist of the NMDA/glycine receptor. Eur J Pharmacol 1992;221:249-254.
20. Garofalo P, Colombo S, Lanza M, Revel L, Makovec F. CR 2249: A new putative memory enhancer. Behavioural studies on learning and memory. J Pharm Pharmacol 1996;48:1290-1297.
21. German DC, Manaye KF, White III CL, et al. Disease-specific patterns of locus coeruleus cell loss. Ann Neurol 1992;32:667-676.
22. Gramsbergen JBP, Schmidt W, Turki WA, Schwarcz R. Age-related changes in kynurenic acid production in rat brain. Brain Res 1992;588:1-5.
23. Granger R, Staubli U, Davis M, et al. A drug that facilitates glutamatergic transmission reduces exploratory behaviour and improves performance in a learning-dependent task. Synapse 1993;15:326-329.
24. 3H]ifenprodil binding in rat brain. Eur J Pharmacol 1994;266:67-77.
25. Homma A, Hasegawa K. Recent clinical trials of cholinomimetics for patients with Alzheimer's disease in Japan. Adv Behav Biol 1995;44:437-448.
26. Hood WF, Compton RP, Monahan JB. D-cycloserine: A ligand for the N-methyl-D-aspartate coupled glycine receptor has partial agonist characteristic. Neurosci Lett 1989;98:91-95.
27. Isaacson JS, Nicoll RA. Aniracetam reduces glutamate receptor desensitation and slows the decay of fast excitatory synaptic currents in the hippocampus. Proc Natl Acad Sci USA 1991;88:10936-10940.
28. Itoh A, Nitta A, Katono Y, Usui M, Naruhashi K. Effects of metrifonate on memory impairment and cholinergic dysfunction in rats. Eur J Pharmacol 1997;322:11-29.
29. Itoh Y, Oishi R, Nishibori M, Saeki K. In vivo measurement of noradrenaline and 3,4-dihydroxyphenyl-ethylenglycol in the rat hypothalamus by microdialysis: Effects of various drugs affecting noradrenaline metabolism. J Pharmacol Exp Ther 1990;255:1090-1097.
30. Izumi Y, Clifford DB, Zorumski CF. Glycine antagonists block the induction of long-term potentiation in CA1 of rat hippocampal slices. Neurosci Lett 1990;112:251-253.
31. Jin S, Fredholm BB. Electrically evoked dopamine and acetylcholine release from rat striatel slices perfused without magnesium: Regulation by glutamate acting on NMDA receptors. Br J Pharmacol 1997;121:1269-1276.
32. Johns CA, Haroutunian V, Greenwall BS, et al. Development of cholinergic drugs for the treatment of Alzheimer's disease. Drug Dev Res 1985;5:77-96.
33. Johnson JW, Ascher P. Glycine potentiates the NMDA response in cultured mouse brain neurons. Nature 1987;325:529-531.
34. 3H]norepinephrine release. J Pharmacol Exp Ther 1987;240:492-497.
35. Kemp JA, Leeson PD. The glycine site of the NMDA receptor five years on. TIPS 1993;14:20-25.
36. Kleckner NW, Dingledine R. Requirement for glycine in activation of NMDA-receptors expressed Xenopus oocytes. Science 1988;241:835-837.
37. Lanza M, Bonnafous C, Colombo S, Revel L, Makovec F. Characterization of a novel putative cognition enhancer mediating facilitation of glycine effect on strychnine-resistant sites coupled to NMDA receptor complex. Neuropharmacology 1997;36:1057-1064.
38. Lanza M, Revel L, Makovec F. Norepinephrine releasing mechanism by CR 2249, a putative nootropic drug. TINS 1997;20:47.
39. MacDermott AB, Mayer ML, Westbrook GL, Smith SJ, Barker JL. NMDA receptor activation increases cytoplasmatic calcium concentration in cultured spinal cord neurons. Nature 1986;321:519-522.
40. Makovec F, Peris W, Rovati LC, Rovati L A. Preparation of derivatives of glutamic and aspartic acids, as drugs for enhancing memory and learning. Chem Abstr 1995;122:P291526q.
41. Martin JR, Haefely WE. Pharmacology of aniracetam - A novel pyrrolidinone derivative with cognition enhancing activity. Drug Invest 1993;5:4-49.
42. Mohammed AH. Effects of cholinesterase inhibitors on learning and memory in rats: a brief review with special reference to THA. Acta Neurol Scand Suppl 1993;149:13-15.
43. Mohr E, Knott V, Sampson M, Wesnes K, Herting R, Mendis T, Cognitive and quantified electroencephalographic correlates of cycloserine treatment in Alzheimer's disease. Clin Neuropharmacol 1995;18:28-34.
44. Monaghan DT, Bridges RJ, Cotman CVV. The excitatory amino acid receptors: Their classes, pharmacology and distinct properties in the function of the Central Nervous System. Am Rev Pharmacol 1989;29:365-402.
45. Mondadori C, Classen W, Borkowski J, Ducret T, Bucrki H, Schade A. Effects of oxiracetam on learning and memory in animals: Comparison with piracetam. Clin Neuropharmacology 1986;9:S27.
46. Mondadori C, Etienne P. Nootropic effects of ACE inhibitors in mice. Pychopharmacology 1990;100:301-307.
47. Monyer H, Sprengel R, Schoepfer R, et al. Heteromeric NMDA receptors: Molecular and functional distinction of subtypes. Science 1992;256:1217-1221.
48. Moroni F, Russi P, Carlà V, Lombardi G. Kynurenic acid is present in the rat brain and its content increases during development and aging process. Neurosci Lett 1988;94:145-150.
49. Moroni F, Russi P, Lombardi G, Beni M, Carlà V. Presence of kynurenic acid in the mammalian brain. J Neurochem 1988;51:177-180.
50. 3H]-CGS 19755: A novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain. Br J Pharmacol 1988;95:932-938.
51. Murphy SN, Thayer SA, Miller RJ. The effects of excitatory amino acids on intracellular calcium in single mouse striatal neurons in vitro. J Neurosci 1987;7:4145-4158.
52. Oliver MW, Kessler M, Larson J, Schottler F, Lynch G. Glycine site associated with the NMDA receptor modulates long-term potentiation. Synapse 1990;5:265-269.
53. i sensitive dye indo-1. Neuropharmacology 1995;34:35-42.
54. Pittaluga A, Fedele E, Risiglione C, Raiteri M. Age-related decrease of the NMDA receptor-mediated noradrenaline release in rat hippocampus and partial restoration by D-cycloserine. Eur J Pharmacol 1993;231:129-134.
55. Pittaluga A, Pattarini R, Raiteri M. Putative cognition enhancers reverse kynurenic acid antagonism at hippocampal NMDA receptors. Eur J Pharmacol 1995;272:203-209.
56. Pugliese AM, Corradetti R, Ballerini L, Pepeu G. Effect of the nootropic drug oxiracetam on field potentials of the rat hippocampal slices. Br J Pharmacol 1990;99:189-193.
57. 3H]noradrenaline release by activating a strychnine-sensitive receptor present in rat hippocampus. Eur J Pharmacol 1990;184:239-250.
58. Randolph C, Roberts JW, et al. D-cycloserine treatment of Alzheimer disease. Alzhsimer Dis Assoc Disord 1994;8:198-203.
59. 3H]norepinephrine release is modulated by glycine. Eur J Pharmacol 1988;156:149-153.
60. 3H]MK-SOl binding to the N-methyl-D-aspartate receptor ion-channel complex by L-glutamate, glycine, and polyamines. J Neurochem 1988;51:830-836.
61. 3H]-labeled MK-801 binding to the excitatory amino acid receptor complex from rat brain is enhanced by glycine. Proc Natl Acad Sci USA 1987;84:7744-7748.
62. Riekkinen PJ, Schmidt B, Stefanski R, Kuitunen J, Riekkinen M. Metrifonate improves spatial navigation and avoidance behaviour in scopolamine-treated, medial septum-lesioned and aged rats. Eur J Pharmacol 1996;309:121-130.
63. Rogers SL, Friedhoff LT. The efficacy and safety of donepezil in patients with Alzheimer's disease: Results of a US multicentre, randomized, double-blind, placebo-controlled trial. Dementia 1996;7:293-303.
64. 3H]N-(1-[thienyl]cyclohexyl)piperidine binding to the N-methyl-D-aspartate receptor ionophore complex. Mol Pharmacol 1990;37:572-577.
65. Scali C, Giovannini MG, Bartolini L, et al. Effect of metrifonate on extracellular brain acetylcholine and object recognition in aged rats. Eur J Pharmacol 1997;325:173-180.
66. Schuster GM, Schmidt WJ. D-cycloserine reverses the working memory impairment of hippocampal-lesioned rats in a spatial learning task. Eur J Pharmacol 1992;224:97-98.
67. Staubli U, Rogers G, Lynch G. Facilitation of glutamate receptors enhances memory. Proc Natl Acad Sci USA 1994;91:777-781.
68. Summers WK, Majovski LV, Marsh GM, Tachiki K, Kling A. Oral tetrahydroaminoacridine in long-term treatment or senile dementia, Alzheimer type. N Engl J Med 1986;315:1241-1245.
69. Vanderwolf CH, Cain DP. The behavioral neurobiology of learning and memory: A conceptual reorientation. Brain Res Rev 1994;19:264-297.
70. 3H]norepinephrine release from hippocampal slices is an in vitro biochemical tool for investigating the pharmacological properties of excitatory amino acid receptors. J Neurochem 1987;49:1438-1442.
71. Watanabe Y, Himi T, Saito H, Abe K. Involvement of glycine site associated with the NMDA receptor in hippocampal long-term potentiation and acquisition of spatial memory in rats. Brain Res 1992;582:58-64.
72. Watanabe Y, Saito H, Abe K. Effects of glycine and structurally related amino acids on generation of long-term potentiation in rat hippocampal slices. Eur J Pharmacol 1992;223:179-184.
73. Watkins PB, Zimmerman HJ, Knapp MJ, Gracon SI, Lewis KW. Hepatotoxic effects of tacrine administration in patients with Alzheimer's disease. JAMA 1994;271:991-998.
74. 3H]MK-801 to the N-methyl-D-aspartate receptor: Pharmacological evidence for the existence of a polyamine recognition site. Mol Pharmacol 1989;36:575-581.
75. Wilson CA. Society for drug research symposium: Senile dementia of the Alzheimer type. Neurobiol Aging 1986;7:219-222.